BioMark Diagnostics Overview
Valuation check: BUX.CN's PEG ratio is 315.88, above the sector sector average of 10.05.
Get informed when a big investor buys or sells
+ Follow315.88
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
BioMark Diagnostics (BUX.CN) currently reports a PEG ratio of 315.88. That is above the sector sector average of 10.05. Use the charts on this page to explore BioMark Diagnostics's PEG ratio history and peer comparisons.
BioMark Diagnostics's PEG ratio of 315.88 is higher than the its sector sector average of 10.05. That is roughly 3041.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates BioMark Diagnostics's market price to a fundamental measure such as earnings, sales, or book value. At 315.88, BUX.CN can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of 315.88, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 10.05. From there, open related valuation or income-statement pages for BioMark Diagnostics, and consider following BUX.CN for alerts when major investors trade the stock.
